<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/29004/myeloma-debate-is-mrd-ready-for-prime-time-yes?channelName=HMP+CME&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Myeloma Debate: Is MRD Ready for Prime Time? - Yes

Name: Myeloma Debate: Is MRD Ready for Prime Time? - Yes
Uploaded: 2019-06-04T02:42:54
Duration: 21 min 17 s
Description: Earn CME: https://naccme.com/program/7329 In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Prashant Kapoor agues that MRD should be the treatment target for patients with multiple...

00:21:17

HMP CME

3 years 151 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/29004/myeloma-debate-is-mrd-ready-for-prime-time-yes?channelName=HMP+CME&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/29004/myeloma-debate-is-mrd-ready-for-prime-time-yes?channelName=HMP+CME&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/29004/myeloma-debate-is-mrd-ready-for-prime-time-yes?channelName=HMP+CME&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/29004?channelName=HMP+CME"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190604144254_237f/video_190604144254_237f.jpg?cache=15669162641678829655">Myeloma Debate: Is MRD Ready for Prime Time? - Yes</a>

Link (BBCode):

[url=https://oncologytube.com/v/29004?channelName=HMP+CME][img]https://oncologytubecom.cdn.ypt.me/videos/video_190604144254_237f/video_190604144254_237f.jpg?cache=15669162641678829655[/img]Myeloma Debate: Is MRD Ready for Prime Time? - Yes[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Multiple Myeloma

Description:

Earn CME: https://naccme.com/program/7329

In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Prashant Kapoor agues that MRD should be the treatment target for patients with multiple myeloma.

© 2019 Imedex, an HMP Company